BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31647697)

  • 1. Patterns of Care and Costs for Older Patients With Colorectal Cancer at the End of Life: Descriptive Study of the United States and Canada.
    Bremner KE; Yabroff KR; Coughlan D; Liu N; Zeruto C; Warren JL; de Oliveira C; Mariotto AB; Lam C; Barrett MJ; Chan KK; Hoch JS; Krahn MD
    JCO Oncol Pract; 2020 Jan; 16(1):e1-e18. PubMed ID: 31647697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
    Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
    Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-of-life care for lung cancer patients in the United States and Ontario.
    Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
    J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada.
    Ho TH; Barbera L; Saskin R; Lu H; Neville BA; Earle CC
    J Clin Oncol; 2011 Apr; 29(12):1587-91. PubMed ID: 21402603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.
    Bekelman JE; Halpern SD; Blankart CR; Bynum JP; Cohen J; Fowler R; Kaasa S; Kwietniewski L; Melberg HO; Onwuteaka-Philipsen B; Oosterveld-Vlug M; Pring A; Schreyögg J; Ulrich CM; Verne J; Wunsch H; Emanuel EJ;
    JAMA; 2016 Jan; 315(3):272-83. PubMed ID: 26784775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
    Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
    J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family Perspectives on Aggressive Cancer Care Near the End of Life.
    Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
    JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in end-of-life care and health care spending in women with uterine cancer.
    Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The end of life costs for Medicare patients with advanced ovarian cancer.
    Urban RR; He H; Alfonso R; Hardesty MM; Goff BA
    Gynecol Oncol; 2018 Feb; 148(2):336-341. PubMed ID: 29208368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Health Care Utilization at the End of Life Among Patients With Cancer in Alberta, Canada, Versus Washington State.
    Khaki AR; Xu Y; Cheung WY; Li L; Fedorenko C; Grivas P; Ramsey S; Shankaran V
    JCO Oncol Pract; 2020 Dec; 16(12):e1543-e1552. PubMed ID: 32804586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive Care near the End of Life for Cancer Patients in Medicare Accountable Care Organizations.
    Kim H; Keating NL; Perloff JN; Hodgkin D; Liu X; Bishop CE
    J Am Geriatr Soc; 2019 May; 67(5):961-968. PubMed ID: 30969439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector.
    Keating NL; Landrum MB; Lamont EB; Earle CC; Bozeman SR; McNeil BJ
    Cancer; 2010 Aug; 116(15):3732-9. PubMed ID: 20564065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States.
    Groome PA; O'Sullivan B; Irish JC; Rothwell DM; Schulze K; Warde PR; Schneider KM; Mackenzie RG; Hodson DI; Hammond JA; Gulavita SP; Eapen LJ; Dixon PF; Bissett RJ; Mackillop WJ
    J Clin Oncol; 2003 Feb; 21(3):496-505. PubMed ID: 12560441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.
    Dinan MA; Li Y; Zhang Y; Stewart SB; Curtis LH; George DJ; Reed SD
    Clin Genitourin Cancer; 2016 Feb; 14(1):28-37.e2. PubMed ID: 26382223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life.
    Stuver SO; McNiff K; Fraile B; Odejide O; Abel GA; Dodek A; Jacobson JO
    J Pain Symptom Manage; 2016 Aug; 52(2):161-9. PubMed ID: 27033156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003.
    Walker H; Anderson M; Farahati F; Howell D; Librach SL; Husain A; Sussman J; Viola R; Sutradhar R; Barbera L
    J Palliat Care; 2011; 27(2):79-88. PubMed ID: 21805942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between survival time with metastatic breast cancer and aggressive end-of-life care.
    Accordino MK; Wright JD; Vasan S; Neugut AI; Gross T; Hillyer GC; Hershman DL
    Breast Cancer Res Treat; 2017 Nov; 166(2):549-558. PubMed ID: 28752188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.